CDT Environmental Technology Investment Holdings Limited - ordinary shares (CDTG)
1.1500
+0.1700 (17.35%)
NASDAQ· Last Trade: Aug 27th, 1:44 AM EDT
August 26, 2026 — Drug discovery can begin with 5,000 to 10,000 compounds, narrow to approximately 250 entering preclinical development , around five reaching clinical trials and ultimately produce just one approved medicine —highlighting why identifying weak drug candidates earlier can be critical to pharmaceutical R&D.
Via AB Newswire · August 26, 2026
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CDT Environmental Technology Investment Holdings Ltd. (NASDAQ: CDTG) resulting from allegations that CDT Environmental may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · April 10, 2026
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CDT Environmental Technology Investment Holdings Ltd. (NASDAQ: CDTG) resulting from allegations that CDT Environmental may have issued materially misleading business information to the investing public.
By Rosen Law Firm, P.A. · Via Business Wire · April 9, 2026

WestPark Capital today announced the closing of a $6,000,000 IPO for CDT Environmental Technology Investment Holdings Limited (“CDT”). CDT is a waste treatment company that designs, develops, manufactures, sells, installs, operates and maintains sewage treatment systems and provides sewage treatment services in China. The IPO consisted of 1,500,000 ordinary shares at a public offering price of $4.00 per share resulting in gross proceeds of $6,000,000, before offering expenses.
By WestPark Capital, Inc. · Via Business Wire · April 23, 2024